Search results
Missed Out on Novo Nordisk? This Much Smaller Danish Biotech Could Be the Next Hot Weight-Loss...
Motley Fool via Yahoo Finance· 2 months agoA big focus for healthcare companies recently has been on the weight-loss industry. It's no...
Weight-Loss Tizzy: Why Altimmune Surged 23% As Others Tumbled On A New Study
Investor's Business Daily· 2 months agoBiotech stocks Akero Therapeutics and Altimmune, diverged Monday as Wall Street debated the outcome...
Potential weight-loss drug meets goals in mid-stage trial as race accelerates
Reuters via Yahoo News· 12 months agoFRANKFURT (Reuters) -Denmark's Zealand Pharma and Boehringer Ingelheim said their experimental...
Obesity drug from Boehringer, Zealand succeeds in MASH trial
BioPharma Dive via Yahoo Finance· 2 months agoZealand shares rose by more than one-third on the data, which provide further evidence so-called...
UPDATE 2-Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
Reuters via Yahoo Finance· 12 months agoZealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to 14.9% weight loss after 46 weeks in a mid-stage trial, adding a potential contestant to the ...
Zealand shares surge on liver drug data from Boehringer pact
Reuters via Yahoo News· 2 months agoFRANKFURT (Reuters) -Shares in Zealand Pharma soared 34% on Monday after an experimental weight-loss drug it is developing with Boehringer Ingelheim yielded what they called "groundbreaking" ...
Boehringer to test obesity drug in three late-stage trials
Reuters via Yahoo News· 9 months agoThe private company plans to start enrollments for the trial of the drug, survodutide, which it co-invented with Danish biotech company Zealand Pharma, before the end of the year. The trials ...
Weight loss drug windfall attracts pharma companies
Reuters via Yahoo News· 4 months agoSAN FRANCISCO (Reuters) -Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting...
Factbox-Weight-loss drugs: the next gold rush
Reuters via Yahoo News· 12 months agoThe enormous demand for weight-loss treatments like Wegovy could support as many as 10 competing products with annual sales reaching up to $100 billion...
Walgreens inks GLP-1 clinical trial deal with major German drugmaker
Healthcare Dive via Yahoo Finance· 5 days agoUnder the deal, Walgreens will find candidates who are overweight or have obesity or diabetes and...
